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Long non-coding RNAs (lncRNAs) have been recently recognized as a major class of regulators in
mammalian systems. LncRNAs function by diverse and heterogeneous mechanisms in gene regulation,
and are key contributors to development, neurological disorders, and cancer. This emerging importance
of lncRNAs, along with recent reports of a functional lncRNA encoded by the mouse Dlx5-Dlx6 locus, led
us to interrogate the biological signiﬁcance of another distal-less antisense lncRNA, the previously
uncharacterized Dlx1 antisense (Dlx1as) transcript. We have functionally ablated this antisense RNA via
a highly customized gene targeting approach in vivo. Mice devoid of Dlx1as RNA are viable and fertile,
and display a mild skeletal and neurological phenotype reminiscent of a Dlx1 gain-of function
phenotype, suggesting a role for this non-coding antisense RNA in modulating Dlx1 transcript levels
and stability. The reciprocal relationship between Dlx1as and Dlx1 places this sense–antisense pair into
a growing class of mammalian lncRNA-mRNA pairs characterized by inverse regulation.
& 2013 Elsevier Inc. All rights reserved.Introduction
Increasing evidence points to a role for non-coding RNAs (ncRNAs)
in development and disease, a ﬁeld rapidly gaining importance
(Babajko et al., 2009; Berdal et al., 2002; Blin-Wakkach et al., 2001;
Brockdorff et al., 1991; Chen and Carmichael, 2010; Clemson et al.,
1996; Costa, 2010; Eberhart et al., 2008; Faghihi and Wahlestedt,
2009; Feng et al., 2006; Ginger et al., 2006; Gupta et al., 2010;
Lipovich et al., 2010; Lyle et al., 2000; Nagano et al., 2008; Qureshi
et al., 2010; Rinn et al., 2007; Sana et al., 2012; St Laurent et al., 2009;
Wang and Chang, 2011; Wang et al., 2011; Young et al., 2005).
NcRNAs include microRNAs (miRNAs) and long non-coding RNAs
(lncRNAs), with an emerging class of lncRNAs that act as endogenous
riboregulators of transcription factors (TFs), including lncRNAs that
directly bind TF proteins to regulate them (Chen and Carmichael,
2010; Costa, 2010; Hung and Chang, 2010; Hung et al., 2011; Kino
et al., 2010; Lipovich et al., 2010; Martianov et al., 2007; Redon et al.,
2010; Sana et al., 2012; Wang and Chang, 2011). Intriguing examples
of these regulators include the lncRNA GAS5, a ribo-mimic of the
genomic-DNA glucocorticoid receptor binding site and hence a direct
suppressor of endogenous glucocorticoid receptor binding to genomic
targets (Kino et al., 2010), and SRA, whose lncRNA isoform activates
estrogen receptor alpha through a shared ribonucleoprotein complex
(Chooniedass-Kothari et al., 2010). Amongst the lncRNAs we ﬁnd a
large group of endogenous antisense RNAs (also known as naturalll rights reserved.
).antisense transcripts, NATs), transcribed from complex genetic loci on
the opposite strand of protein-coding transcripts (Feng et al., 2006;
Katayama et al., 2005; Rinn et al., 2007; Sleutels et al., 2002; Thakur
et al., 2004). LncRNA NATs are frequently related to TF-encoding
genes (Werner, 2005). Several mechanisms of these RNAs have been
suggested (Vanhee-Brossollet and Vaquero, 1998). NATs, including
lncRNAs, may overlap exons and/or introns of their associated sense
transcripts, and can mediate or regulate gene expression in cis and/or
in trans (for reviews see (Costa, 2010; Lipovich et al., 2010; Sana et al.,
2012; Wang and Chang, 2011). Recently, a connection between NATs
and potential pathological changes in the CNS has been established
for BdnfmRNA and Bdnf-as lncRNA by employing a siRNA knockdown
strategy (Modarresi et al., 2012).
While Dlx1 antisense (Dlx1as) RNA has been described pre-
viously (Dinger et al., 2008; Jeong et al., 2008; Liu et al., 1997;
McGuinness et al., 1996) to date it remains to be deﬁned whether
the naturally occurring Dlx1as transcript has any function or
should be considered as mere transcriptional noise. The genomic
region encoding the Dlx1as RNA is embedded between two well-
characterized genes: Dlx1 and Dlx2 (McGuinness et al., 1996),
homeobox-containing transcription factors that are part of distal-
less, an evolutionarily conserved gene family (Depew et al., 2005;
Kraus and Lufkin, 1999; McGuinness et al., 1996). While the
Dlx homeoproteins are key transcriptional regulators of down-
stream target genes with crucial roles in craniofacial and appen-
dicular skeleton as well as neurological development (Cobos et al.,
2005; Depew et al., 2005; Jeong et al., 2008; Jones et al., 2011;
Mao et al., 2009; Petryniak et al., 2007; Robledo et al., 2002), and
the Evf2 lncRNA, a NAT of the Dlx5-Dlx6 locus, has been identiﬁed
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Feng et al., 2006), little is known about the Dlx1as RNA (Dinger
et al., 2008; Liu et al., 1997; McGuinness et al., 1996). Recent
ﬁndings regarding a role of Dlx1 in behavioral abnormalities in
mice such as hyperactivity, reduced fear response and epilepsy
(Cobos et al., 2005; Jones et al., 2011; Mao et al., 2009; Petryniak
et al., 2007) alongside implications of lncRNAs (reviewed in
(Qureshi et al., 2010)) and miRNAs (reviewed in (Meza-Sosa
et al., 2012)) in the development of the central nervous system
(CNS) and their potential role as causal agents or modulator in
different types of neurodegenerative diseases, led us to investi-
gate whether the Dlx1as RNA had a function.
Mice devoid of Dlx1 die within 1 month after birth when
maintained on a C57BL/6 genetic background (Qiu et al., 1997;
Wonders and Anderson, 2005). In outbred mice, expression of
Dlx1 is crucial for the survival of somatostatin (somþ) and
neuropeptideY (NPYþ) producing GABAeric interneurons that
undergo increased apoptotic cell death in adult Dlx1 loss-of-
function mice (Cobos et al., 2005). The observed behavioral
phenotypes in these mice have been attributed to this loss of
subtype-speciﬁc interneurons as a consequence of the introduc-
tion of a gene targeted 2.8 kb deletion in the Dlx1 locus, removing
all of exons 2 and 3 (Cobos et al., 2005; Qiu et al., 1997). Such a
deletion inadvertently would have also affected if not deleted the
genomic region encoding the Dlx1as RNA (McGuinness et al.,
1996). Exons of the Dlx1 gene, including speciﬁcally a region that
encodes the homeobox domain portion highly conserved at the
amino acid level relative to Dlx2, are overlapped in the opposite
direction by exons of the Dlx1as RNA. Here, to investigate any
possible function of the Dlx1as RNA, we truncated the Dlx1as RNA
using gene targeting to abolish Dlx1as expression and hence any
potential hybridization between the Dlx1as and Dlx1 sense
transcripts, providing an in vivo analysis of an endogenous
antisense lncRNA by a gene-targeted, loss-of-function approach.
To date our study is the second to target an lncRNA that regulates
distal-less homeobox genes (Bond et al., 2009). Our gene targeting
was carefully customized based on bioinformatic evidence to
ensure a truncation of the Dlx1as RNA upstream of the sequence
allowing for potential hybridization while leaving the surround-
ing Dlx1 and Dlx2 locus unaffected. The mice homozygous for the
targeted allele are viable and fertile with mild skeletal and
neurological phenotypes demonstrating the biological relevance
of the Dlx1as RNA as a modulator of the Dlx1 transcript levels.
Functionally ablating the Dlx1as RNA essentially replicates a Dlx1
gain-of-function phenotype. We therefore suggest that the non-
coding Dlx1as RNA has an endogenous role as a negative regulator
of Dlx1 mRNA and may ﬁne-tune Dlx1 transcript availability.Material and methods
Construct design and generation of Dlx1as4xPA/4xPA mice
A 13149 bp long homology arm (LHA) and a 1204 bp short
homology arm (SHA) were used to target the endogenous Dlx1as
locus by homologous recombination in R1 ES cells. A loxPpgkGb2Neo-
loxP selection cassette followed by four polyadenylation sites (4xPA)between Exon 1 and Exon 2 of the sequence encoding for the Dlx1as
RNA or 30 to Exon 3 of the Dlx1 gene respectively, precisely by deleting
160 bp between position 102651 and 102811 of AL928931 (see
Fig. 1). This design will leave the Dlx1 sense coding region as well
as known conserved enhancer elements intact (Ghanem et al., 2003;
McGuinness et al., 1996).Dlx1as RNA validation by RT–PCR and quantiﬁcation of embryonic
gene expression levels in Dlx1as4xPA/4xPA mice
Total RNA was isolated from fresh brains of P28 adult mice or
from fresh E13.5 or formalin-ﬁxed and parafﬁn embedded (FFPE)
E13.5 embryos using either TRIzol reagent (Invitrogen) or High
Pure FFPE RNA Kit (Roche) according to manufacturer’s instruc-
tions. After the ﬁnal RNA precipitation step, RNA samples from
fresh tissue were treated with TurboTM DNase (Ambion) before the
ﬁnal puriﬁcation by passing through RNeasy columns (QIAGEN).
Yield and quality of RNA was determined with a NanoDrop
spectrometer (NanoDrop Technology). First strand cDNA was
synthesized from 5 mg (fresh) to 0.5 mg (FFPE) of total RNA by
reverse transcription (RT) PCR at 50 1C for 30 min in the presence
of 200 ng/ml random hexamers and 10 mM each of dNTPs and
RevertAidTM Premium Enzyme mix (Fermentas). cDNA samples
were diluted in DNAse-free water 1:5 prior to reverse transcrip-
tion (RT)–PCR or 1:10 prior to real-time PCR (qPCR). RT–PCR and
qPCR were performed to conﬁrm Dlx1as RNA expression was
abrogated in Dlx1as4xPA/4xPA mice. cDNA reverse transcribed from
mRNA isolated from Dlx1as4xPA/4xPA and Dlx1asþ /þ mice were
ampliﬁed by PCR using a primer pair designed to amplify the
Dlx1as transcript. The quality of cDNA samples was assessed by
their ampliﬁcation in the presence or absence of reverse tran-
scriptase to conﬁrm that the absence of the Dlx1as RT–PCR
product in Dlx1as4xPA/4xPA mice was not an artiﬁcial result of
deterioration of RNA samples or DNA contaminiation. RT-PCR
reactions were carried out in total volumes of 50 ml and included
400 nM of each primer and 5 ml of diluted cDNA template contain-
ing 250 ng cDNA. PCR thermocycling conditions for the Dlx1as
transcript were 93 1C for 3 min, 93 1C for 15 s, 51 1C for 30 s, 68 1C
for 1 min 30 s; for 35 cycles using LongRange PCR enzyme mix
(Qiagen). B2m was ampliﬁed at 93 1C for 3 min, 93 1C for 15 s,
58 1C for 30 s, 68 1C for 1 min; for 35 cycles using LongRange PCR
enzyme mix. Gel electrophoresis analysis of the RT–PCR products
indicated a nucleic acid band of 1184 bp, the size expected for the
Dlx1as cDNA PCR product. Control reactions without reverse
transcriptase produced no such DNA fragment, indicating the
observed RT–PCR product was not a result of ampliﬁcation of
contaminating genomic DNA. For qPCR the transcript of either the
housekeeping gene b2-microglobulin (B2m), Hprt or b-Actin was
used as a calibrator. For qPCR validation of expression levels of
Dlx1, Dlx2, Olig2, Mash1 and Gad67 total RNA was extracted from
heads of three biological replicates of Dlx1as4xPA/4xPA and Dlx1asþ /þ
E13.5 FFPE embryos each. Samples were run as technical triplicates.
qPCR was carried out in a volume of 25 ml on a ABI7500 thermo-
cycler using SYBRgreen (Invitrogen) with primers as listed in the
table below. For statistical signiﬁcance a T-test three analysis with
one tail was performed in Excel.Transcript Primer name Primer sequence ReferenceDlx1as–Exon1 Dlx1as-qPCR-F4 50-ttgctacatcaaatcaaaagggtcg-30 n/a
Dlx1as-qPCR-R4 50-ggacctctttcctccactctgttct-30Dlx1as–Exon2 Dlx1as-qPCR-F3 50-atttattccagtttgcagttgcagg-30 n/a
Dlx1as-qPCR-R3 50-gactgtgacacctagaaccagaggc-30
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Dlx1asE2-SYBRR3 5’-gcctctggttctaggtgtcacagt-30Dlx1as Dlx1as1184-F 50-ttttcttttgctttcctgtc-30 n/a
Dlx1as1184-R 50-tctaaaagttgccaacagcg-30Dlx1 Dlx1-RT-F 50-agagaggaccaatgagcctt-30 (Mu et al., 2004)
Dlx1-RT-R 50-cacggtggatttcaatcggt-30Dlx2 Dlx2-RT-F 50-cttcatccattgccagtgga-30 (Mu et al., 2004)
Dlx2-RT-R 50-aaacatagggactgctgagg-30Olig2 Olig2-RT-F 50-ctggtgtctagtcgcccatc-30 (Stecca and Ruiz i Altaba, 2009)
Olig2-RT-R 50-aggaggtgctggaggaagat-30Mash1 Mash1-RT-F2 50-tctcctgggaatggactttg -30 n/a
Mash1-RT-R2 50-ggttggctgtctggtttgtt-30Gad67 Gad67-RT-F 50-agatagccctgagcgacgag-30 (Sinclair et al., 2010)
Gad67-RT-R 50-atggccgatgattctggttc-30B2M B2M-F 50-ggagaatgggaagccgaaca-30 n/a
B2M-R 50-gcattgggcacagtgacaga-30Hprt qPcr-Hprt-F 50-gcagtacagccccaaaatgg-30 (Lengacher et al., 2004)
qPcr-Hprt-R 50-aacaaagtctggcctgtatccaa-30bActin Actb-RT-F 50-caccctgtgctgctcacc-30 (Sinclair et al., 2010)
Actb-RT-R 50-gcacgatttccctctcag-30Skull morphology assessment by alizarin red and alcian blue staining
Dlx1as4xPA/þ animals were intermated to generate wild type
and homozygous P0 offspring. The P0 neonates were decapitated
following strict IACUC guidelines for euthanasia and genotyped.
After overnight ﬁxation in 100% EtOH the skull was dissected free
of all other tissue types and subjected to alcian blue staining
representing chondrogenic tissue and alizarin red staining char-
acteristic for mineralized tissue as described in (Kraus et al., 2001).Histology
P27 to P30 mice were deeply anesthetized with Avertin
(0.2 mg/10 g body weight) and perfused with cold 4% PFA in
DEPC/PBS and the brains carefully removed from the skull.
Embryos were removed from the uterus of timed pregnant females
at E12.5, E13.5 and decapitated at E15.5, then washed in 1 PBS.
All samples were ﬁxed in an excess volume of 4% PFA in DEPC/PBS
at 4 1C under agitation over night, processed via an automatic
tissue processor (Leica) for parafﬁn embedding and sectioned at
10 um. In situ hybridization was essentially carried out as
described in (Kraus et al., 2012) using the following probes: Dlx1
(IMAGE clone: 30360273) was linearized with EcoRI and tran-
scribed from T3 to generate the antisense probe and linearized
with NotI and transcribed from T7 for the sense probe. The sense
probe was used to detect Dlx1as expression. Mash1/Ascl1 (IMAGE
clone: 6415061), Olig2 (IMAGE clone: 5695592) and Somatostatin
(IMAGE clone: 476246) were linearized with EcoRI and transcribed
from T3, Lhx6 (a donation from Vassilis Pachnis) was linearized
with NotI and transcribed from T3, while Gad67 (IMAGE clone:
5358787) was linearized with SalI and transcribed from T7 to
generate the antisense probe using the DIG RNA labeling kit
(Roche). It is of importance to note that SISH to detect the
expression of Gad67, Somatostatin, Olig2, Mash1, Lhx6, Dlx1 sense
and Dlx1 antisense for several replicates of each genotype within
an age group have been carried out within the same experiment to
allow for comparability. For cell-counts comparable size-deﬁned
areas of horizontal/coronal sections through the hippocampus of
adult brains were selected and neurons positive for a given probe
within this area were accounted for manually similar to what has
been described by Petryniak et al. (2007). The number of neurons
per section was averaged for the sections analyzed.Ethics statement, mouse husbandry and tissue collection
All animal procedures were performed according to the Singa-
pore AnSTAR Biological Resource Center (BRC) Institutional Ani-
mal Care and Use Committee (IACUC) guidelines and the IACUC
protocols employed were reviewed and approved by the afore-
mentioned committee before any animal procedures were under-
taken for this study described here (IACUC Protocols 080348/
110689 and 080377).Results
High sequence conservation is observed not only between the
orthologous human and mouse Dlx1 proteins, but also between the
paralogous, tandemly encoded murine Dlx1 and Dlx2 proteins
(McGuinness et al., 1996). The Dlx1as NAT lncRNA is hence tran-
scribed from an evolutionarily conserved region. Furthermore, the
ﬁrst-intron GT splice donor of Dlx1as is highly conserved throughout
placental mammals, marsupials, and monotremes, according to the
30-species MultiZ alignment in the UCSC Genome Browser. The ﬁrst
antisense intron’s splice acceptor, located inside the Dlx1 30UTR
(Fig. 1) is conserved in eutherian mammals, as are the splice donors
and acceptors of all additional introns located upstream of Dlx1
along the genome, based on the four Genbank accession numbers
(AK132348, BF469576, AK139461, and BB647803). Interestingly,
despite the sequence conservation, the gene structure landscape of
the human DLX1 locus is less well-conserved relative to mouse:
there is no evidence of spliced human cDNAs or ESTs equivalent to
Dlx1as, although this might be merely an outcome of the limited
nature of human cDNA libraries available, compared to the exten-
sive FANTOM3 mouse libraries. While there have been reports of
functional NAT lncRNAs in mouse (for review see (Faghihi and
Wahlestedt, 2009)) in this study, using a highly customized gene
targeting approach, we for the ﬁrst, time demonstrate a Dlx1as loss-
of-function phenotype, making ‘‘sense’’ of the existence of the Dlx1
antisense RNA.
Effective targeting by homologous recombination of the Dlx1as RNA
without disruption of the Dlx1 sense transcript.
We have generated, characterized and validated a functional
ablation of a NAT lncRNA by gene targeting. To generate this allele
Fig. 1. Minimal invasive gene targeting by homologous recombination. The targeting strategy is outlined and essentially drawn to scale introducing a loxPpgkGb2NeoloxP
selection cassette, into the genomic locus of Dlx1 30 to Exon 3 and the Dlx1as intronic region. After Zp3-Cre activity the selection cassette is removed leaving a 160 bp
deletion, one loxP element and four polyadenylation sites behind. This will result in the truncation of the antisense transcript without disruption of the sense locus. RNA-
ISH probes are indicated below (blue boxes). (LHA) long homology arm, (SHA) short homology arm, (Ex) exon, (4xPA) four sequential polyadenylation sites.
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bination in R1 ES cells using a 13,149 bp long homology arm
(LHA) and a 1204 bp short homology arm (SHA) to insert a
loxPpgkGb2NeoloxP selection cassette followed by four polyade-
nylation sites (4xPA) between Exon 1 and Exon 2 of the sequence
encoding for the Dlx1as RNA or the region 30 of the Dlx1 gene
respectively, precisely by deleting 160 bp between position
102651 and 102811 of AL928931 (see Fig. 1). This design will
leave the Dlx1 sense coding region as well as known conserved
enhancer elements intact (Ghanem et al., 2003; McGuinness et al.,
1996). We achieved a targeting efﬁciency of 2% (3 of 148 clones)
validated by Southern blotting (data not shown). The ES cells
were injected into mouse embryos as previously described (Kraus
et al., 2010) to generate germ line transmitting chimeras. The
resulting heterozygous mice Dlx1as4xPA(neo)/þ were normal, viable
and fertile and bred to the ZP3-Cre deleter strain (Lewandoski
et al., 1997) for the removal of the loxP ﬂanked selection cassette
to generate Dlx1as4xPA/þ mice. These were bred to homozygosity
and the Dlx1as4xPA/4xPA homozygous animals remained fertile and
appeared normal (see Fig. 2H–I).
With the minimal invasive targeting strategy described here
four PA sites were introduced to initiate cleavage, truncation and
degradation of the Dlx1as RNA upstream of the sequence capable
of hybridization with the Dlx1 sense transcript. The pA sites,
introduced by our targeting strategy, preclude any hybridization
of Dlx1as with the Dlx1 sense transcript, although the targeting
does not interfere with Dlx1as endogenous transcription initia-
tion. Therefore, this strategy enables us to speciﬁcally determine
whether Dlx1as RNA function in vivo depends on this sense–
antisense overlap. The absence of the Dlx1as RNA in mice homo-
zygous for the targeted 4xPA insertion (Dlx1as4xPA/4xPA) is demon-
strated by qRT–PCR. The beta2-mircoglobulin housekeeping gene
(B2m) was the standard (Fig. 2G).
Discordant regulation of the number of Dlx1-expressing interneurons
in the absence of functional Dlx1as RNA
It has been demonstrated previously that Dlx1 and Dlx2 play an
important role in the fate choice of oligodendral precursor cells(OPC) (Petryniak et al., 2007). In the presence of Dlx1/2 the OPCs will
follow the neuronal pathway, emerging as interneurons, while in
Dlx1/2 loss of function mutants, these precursor cells will follow the
non-neuronal path and emerge as oligodendrocytes, hence essen-
tially supporting glial cells. It has further been reported that Dlx1
positive cells are scattered throughout the hippocampus (Saino-
Saito et al., 2003). In our hands, we have observed a considerable
dynamic in Dlx1 expression when sectioning through the hippo-
campus of several brains in close age range (n¼6) hence we
attempted to compare similar sections of the Dlx1as4xPA/4xPA and
Dlx1asþ /þ across the hippocampus of P27–P30 brains. The absence
of the Dlx1as transcript in sections of Dlx1as4xPA/4xPA animals
compared to those of Dlx1asþ /þ animals (Fig. 2B and C) indicated
again the successful and effective targeting of the Dlx1as locus. We
noted on average a two-fold increase in the number of cells reaching
the threshold of detectable Dlx1 expression in sections through the
hippocampus of Dlx1as4xPA/4xPA (n¼3 brains/n¼76 sections) versus
Dlx1asþ /þ (n¼3 brains/n¼72 sections) P27–P30 brains (Fig. 3A),
essentially generating a Dlx1 gain-of function phenotype as conse-
quence of the functional ablation of the Dlx1 antisense NAT lncRNA.
The phenotype of the Dlx1as4xPA/4xPA generated and validated here is
opposing aspects of the Dlx1 and Dlx1/2 loss-of-function mutation,
which reportedly showed an age dependent reduction in a subtype
of GABAeric interneurons of the cortex and hippocampus (Cobos
et al., 2005; Jones et al., 2011). To understand possible consequences
of the surplus of Dlx1 expressing cells, we performed section in-situ
hybridization (SISH) probing for Somatostatin (Som) and Gad67
expression of adjacent sections from Dlx1as4xPA/4xPA versus
Dlx1asþ /þ P27–P30 brains (Fig. 3A). We chose to assay for
Gad67 expression because ISH for Gad67 mRNA allows for a
reliable and complete labeling of GABAeric neurons in the dentate
gyrus (Houser, 2007). Previously, a 30% reduction in the number
of Gad67-expressing neurons in the hippocampus was identiﬁed
in the brains of 1-month old Dlx1 / mice (Cobos et al., 2005;
Petryniak et al., 2007). Interestingly, we have not noticed a change
in the number of GABAeric neurons when assaying for Gad67
expression by SISH, nor in the number of Somþ neurons in the
hippocampus of Dlx1as4xPA/4xPA (n¼4) when comparing them to
Dlx1asþ /þ at P27–P30 (n¼6) (Fig. 3A). Gad67 has also been
Fig. 2. The absence of the Dlx1as transcript is demonstrated by SISH using the sense probe for Dlx1, detecting cells expressing the Dlx1as transcript in the hippocampus of
Dlx1asþ /þ P30 animals in an overview (A) and close ups (B,C), while the Dlx1as transcript is absent in corresponding regions of Dlx1as4xPA/4xPA age matched controls (D–F).
The successful targeting of the Dlx1as locus is further demonstrated by RT-PCR (G) assaying for the presence of the Dlx1as transcript using RNA extracted from P30 brain
samples for Dlx1asþ /þ (lanes 1 and 5) and Dlx1as4xPA/4xPA (lanes 3 and 7) in the presence (lanes 1, 3, 5 and 7) and absence (lanes 2, 4, 6 and 8) of reverse transcriptase using
the presence of the ß2-microglobulin (B2m) transcript as a control. We further demonstrate that the Dlx1as4xPA/4xPA mice are fertile (H) and of overtly normal appearance (I).
Relative expression by qPCR of Dlx1as Exon 1 (primer pair qPCRF4/R4) upstream and Dlx1as Exon 2 (primer pairs qPCRF4/R4 and E2SYBRF3/R3) downstream of the 4xPA
insertion site, shown for RNA extracted from two Dlx1as4xPA/4xPA (#270, #275) and one Dlx1asþ /þ E13.5 embryos.
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Fig. 3. Neurochemical changes in the ganglionic eminences in the absence of Dlx1as
transcript without a detectable impact on the adult GABAeric interneuron number
is demonstrated by SISH on coronal/horizontal sections (A). Dlx1as expression is
abolished while Dlx1 expression is increased in Dlx1as4xPA/4xPA embryos at E12.5,
E13.5 and E15.5 compared to age and region matched Dlx1asþ /þ controls. Serial
sections of Dlx1, Olig2 andMash1 expression are analyzed at E12.5 and E15.5. While
Dlx1 expression is elevated at both stages in Dlx1as4xPA/4xPA embryos compared to
the control, Olig2 and Mash1 appear unchanged at E12.5, but by E15.5 Mash1
expression appears more diffuse in the VZ and SVZ of Dlx1as4xPA/4xPA embryos. While
in the absence of functional Dlx1as RNA the number of Dlx1 expressing cells remains
about two-fold higher in the hippocampus of Dlx1as4xPA/4xPA adults compared to age
and regionmatched controls, the number of GABAeric neurons assayed for by Gad67
and Somatostatin expression remains unchanged. In embryos however, reduced
levels of Gad67 expression can be observed in Dlx1as4xPA/4xPA embryos compared to
Dlx1asþ /þ controls by E15.5. Abbreviations: (LV) lateral ventricle, (VZ) ventricular
zone, (SVZ) subventricular zone, (T) thalamic region, (E) eye, (MGE) medial gang-
lionic eminence, (LGE) lateral ganglionic eminence. Relative quantiﬁcation of
expression levels for Dlx1, Dlx2, Olig2, Mash1 and Gad67 at E13.5 by qPCR validation
of total RNA form Dlx1as4xPA/4xPA FFPE heads (4xPA/4xPA) compared to Dlx1asþ /þ
FFPE heads (þ/þ). One-tailed Student’s test 3,** po0.005 (B). (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version
of this article.)
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the Dlx5/Dlx6 locus paralogous to the Dlx1/Dlx2 locus, yet in the
adult brain Gad67 expression levels are described as normal, yet
reduced in the embryonic brain in the absence of Evf2 (Bond et al.,
2009) as well as in the Dlx1/2 loss-of-function mutation (Petryniak
et al., 2007). Analyzing Gad67 expression in the embryonic brain
of Dlx1as4xPA/4xPA versus Dlx1asþ /þ by SISH at E12.5 (n¼3) and
E15.5 (n¼4) Gad67 expression appeared reduced in Dlx1as4xPA/4xPA
embryos (Fig. 3) when comparing matching sections for both
genotypes by SISH (Fig. 3A), yet no signiﬁcant difference in Gad67
expression levels was detected by qPCR using RNA extracted from
entire heads (n¼18, Fig. 3B). An additional interneuron marker
Lhx6 was analyzed by SISH and showed clearly reduced expression
by E15.5 in Dlx1as4xPA/4xPA embryos (Fig. 3A). This ﬁnding attests to
similar mechanism for two different NAT lncRNAs, Evf2 (the NAT
lncRNA of the Dlx5/Dlx6 locus) and Dlx1as (the NAT lncRNA of the
Dlx1 locus) targeting two different Dlx family members, both
possibly affecting early, but not late interneuron development.Does Dlx1as RNA impact on oligodendral precursor cell fate decision?
In the mouse forebrain, the ﬁrst of three rounds of progenitor
cells are restricted to the oligodendroglial lineage. These oligo-
dendral precursor cells (OPC) can be found by E13.5 (Kessaris
et al., 2006; Nery et al., 2001; Parras et al., 2007; Petryniak et al.,
2007; Pringle and Richardson, 1993; Tekki-Kessaris et al., 2001).
While the formerly debated origin of OPCs appears to have been
established, the complex molecular mechanisms underlying the
subsequent neuronal–glial fate decision are still to be determined
(Kessaris et al., 2006; Petryniak et al., 2007; Richardson et al.,
2006). Mash1 has been demonstrated to be involved in neurogen-
esis and oligodendrogenesis (Casarosa et al., 1999; Parras et al.,
2007), Olig2 in oligodendrogenesis (Miyoshi et al., 2007; Zhou
et al., 2001) and Dlx1 and Dlx2 play a role in facilitating the
differentiation of GABAeric neurons (Panganiban and Rubenstein,
2002). Given our observation of a two-fold increase in cells
reaching the threshold for detectable Dlx1 sense expression in
the hippocampus of adult Dlx1as4xPA/4xPA mice, reﬂecting essen-
tially a Dlx1gain-of-function phenotype, we aimed to understand
a possible role of Dlx1as RNA in this complex neural/glial fate
decision process of OPCs. We analyzed Dlx1, Olig2 and Mash1
expression at embryonic time points by SISH of sections through
the developing brain. We have noted an increase in Dlx1 expres-
sion in sections of Dlx1as4xPA/4xPA embryos at E12.5, E13.5 and
E15.5, when comparing them to age matched Dlx1asþ /þ controls
(Fig. 3A), a signiﬁcant 1.4 increase in Dlx1 expression compar-
ing Dlx1as4xPA/4xPA versus Dlx1asþ /þ was validated by qPCR for
RNA isolated from entire heads at E13.5 (n¼18, p-value: 0.0047),
while Dlx2 expression was not signiﬁcantly affected in this group
(Fig. 3B). Adjacent sections were analyzed for the expression of
Olig2 and Mash1, both genes being critically involved in OPC fate
decision (Petryniak et al., 2007). At E12.5, just a day after the
estimated onset of oligodendrogenesis in the mouse forebrain
(Kessaris et al., 2006) we did not observe a consistent difference
in Olig2 or Mash1 expression between sections of Dlx1as4xPA/4xPA
and Dlx1asþ /þ embryos (n¼3 embryos/120 sections) by SISH
(Fig. 3A). Quantiﬁcation of expression levels by qPCR for RNA
isolated from entire heads at E13.5 (n¼18) did not indicate any
difference in expression levels for Olig2 (p-value: 0.1824), yet
similar to Dlx1, Mash1 expression was 1.4 upregulated
Dlx1as4xPA/4xPA versus Dlx1asþ /þ embryos (n¼18, p-value:
0.0002) (Fig. 3B). A few days later, by E15.5, at the time when
OPCs are thought to migrate into the cerebral cortex (Kessaris
et al., 2006), Mash1 expression appeared more broadly expressed
in the ventricular and subventricular zone in embryos with
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sections by SISH (n¼4 embryos/80 sections) (Fig. 3A).A dysmorphic alicochlear commissure in the absence of
functional Dlx1as RNA
While mutants of the Dlx family are probably best known for their
neurological abnormalities, the Dlx genes are also crucial players in
determining skull morphology (Depew et al., 2005) hence we further
investigated whether the functional ablation of the lnc Dlx1as RNA
might also inﬂuence skull development. The skull is a complex
structure largely built from branchial arch derivatives and migrating
cranial neural crest cells to encapsulate and protect the vertebrate
brain from external damage. Detailed studies involving chick-quail
chimeras (Couly et al., 1993; Creuzet et al., 2005) have classiﬁed three
major compartments of the avian skull based on their origin which
have been adapted to the mouse skull anatomy (Depew et al., 2005;Fig. 4. Dysmorphology in the alicochlear commissure in the absence of Dlx1as tran
each genotype at P0 are displayed with the yellow arrow head pointing to the ‘‘fene
(right) demonstrating the ‘‘closed-acc’’ phenotype observed in 55% of the analyzed acc
(acc) alicochlear commissure, (alat) anterolateral process of ala temporalis, (bo) basio
(For interpretation of the references to color in this ﬁgure legend, the reader is referreMcBratney-Owen et al., 2008; Qiu et al., 1997) and references therein.
The neurocranium which essentially forms the base of the skull
housing the brain and encapsulating the sense organs, the dermato-
cranium forming the roof of the skull and the splanchnocranium or
viscerocranium, the so called facial skeleton.
Analysis of Dlx1 / mouse skulls at E16.5 and P0 revealed
defects in the neuro- and splanchnocranium such as the absence
of proximal parts of the ala temporalis (at), lateral structures of the
alisphenoid (as) as parts of cartilaginous bridges connecting the
basiphenoid (bs), a paraxial bone of the skull base, to other elements
of the neurocranium, essentially the otic capsule (oc) (Depew et al.,
2005; Qiu et al., 1997). Furthermore the absence of the ventromedial
part of the alisphenoid (as) and in half of the Dlx1 / animals
a smaller stapes and malformed styloid was reported, all three being
considered splanchnocranial elements (Depew et al., 2005;
Qiu et al., 1997). The dermatocranial palatine and pterygoid bones
displayed only a partially penetrant phenotype in the Dlx1 /
mutants with an occasional small cleft palate (Depew et al., 2005;script. Alician blue and alizarin red stained skull bases of three examples for
strae’’ in the acc Dlx1asþ /þ (left) and the absence thereof in the Dlx1as4xPA/4xPA
at P0. Structures were identiﬁed according to Depew et al. (2005). Abbreviations:
ccipital, (bs), basisphenoid, (hzl) horizontal lamina, (pl) palatine, (ptg) pterygoid.
d to the web version of this article.)
P. Kraus et al. / Developmental Biology 376 (2013) 224–235 231Qiu et al., 1997). These same abnormalities and some exceeding
those have been described for Dlx2 / and Dlx1 /Dlx2 / double
mutants (Depew et al., 2005; Qiu et al., 1997).
On the contrary, in the absence of functional Dlx1as RNA we
have never observed an obvious cleft palate nor any obvious
genotype speciﬁc changes in the ossicles when comparing
Dlx1as4xPA/4xPA versus Dlx1asþ /þ P0 and P1 skulls. However, we
did observe a dysmorphic alicochlear commissure (acc), when
comparing postnatal skulls of Dlx1as4xPA/4xPA and Dlx1asþ /þ age
matched pups and E16.5 embryos (see Fig. 4 yellow arrowheads).
The dysmorphology of the acc essentially showed itself in the lack
of a gap observed where the acc bridges towards the oc. This
‘‘closed-acc’’ morphology was observed in 55% of the analyzed acc
(n¼60) of Dlx1as4xPA/4xPA skulls while it could only be seen in 14%
of the analyzed acc (n¼94) of Dlx1asþ /þ skulls, an observation
also made at E16.5 for 36% of Dlx1as4xPA/4xPA acc (n¼14) but none
of the Dlx1asþ /þ acc (n¼20) analyzed (data not shown).Discussion
With increasing knowledge of gene regulatory networks
(GRNs), and increasing evidence pointing to the fact that GRNs
are not restricted to TF target sets, it becomes evident that TFs
themselves might be ﬁne-tuned and modulated post-
transcriptionally by several classes of ncRNAs (Lipovich et al.,
2010). Particularly in the CNS, ncRNAs seem to play an important
role in directing cell fate of neural progenitor cells (NPCs) as well
as reactivity and plasticity of neural cells and their afﬁliated GRNs
in response to external stimuli (for review see (Qureshi et al.,
2010)). We are only beginning to understand possible mechan-
isms of how these ncRNAs might act on their targets, for example
by impacting on sense RNA stability via sense–antisense duplex
formation, targeting the sense transcript for degradation (for
review see (Faghihi and Wahlestedt, 2009; Wang and Chang,
2011)). In recent years the function of a few lncRNAs in gene
regulation has been demonstrated (Babajko et al., 2009; Blin-
Wakkach et al., 2001; Feng et al., 2006; Lyle et al., 2000; Nagano
et al., 2008; Sleutels et al., 2002).
While the actual levels of Dlx1 and or Dlx2 mRNA are likely
causal for any neuropathological or other morphological changes
in Dlx1 and Dlx1/Dlx2 mutant mice, the targeting strategy
described for these mutations would not allow for any functional
analysis of the Dlx1as RNA, as the genomic region encoding the
Dlx1as RNA transcript would have also been deleted (Qiu et al.,
1997). Naturally, the approach to target any NAT of a gene is
difﬁcult, as it is extremely important not to disrupt the function of
the gene itself so to avoid the misattribution of a phenotype as
function of the lncRNA in question in its gene expression
modulating function, development or pathogenesis. Several
approaches have been taken to knockdown antisense RNA using
siRNA technology (Janowski et al., 2007; Modarresi et al., 2012;
Rapicavoli et al., 2011; Sheik Mohamed et al., 2010; Watts et al.,
2010). Often though, the siRNA knockdown methodology suffers
from off-target side effects, impacting on the interpretation of the
resulting phenotype (Clark et al., 2008; Harborth et al., 2003;
Scacheri et al., 2004; Sioud, 2011). Furthermore, given epigenetic
and therefore nuclear functions of many lncRNAs, siRNA knock-
downs are problematic because they employ the cytoplasmic
RNA-Induced Silencing Complex (RISC) and hence do not com-
pletely attenuate lncRNAs whose localization is partly or mostly
nuclear, while commercial antisense oligonucleotide technology
for epigenetic lncRNA targeting is not yet widely available. Hence
it was our uttermost concern to avoid off-target effects and not to
disrupt Dlx1, while rendering the Dlx1as RNA non-functional.
Proof that we have succeeded lies in the fact that the Dlx1asRNA can no longer be detected by either qPCR or RNA-ISH, while
Dlx1 sense RNA is still present and expressed in the appropriate
domains. To date, via homologous recombination (Capecchi,
1989), we have generated the ﬁrst successful functional ablation
of the Dlx1as RNA, a mouse NAT lncRNA, using classic gene-
targeting technology.
The Dlx1as RNA is genomically encoded on the opposite strand
of the Dlx1 gene. According to public cDNA and EST evidence in
Genbank (e.g. AK132348, BF469576, AK139461, and BB647803),
the lncRNA initiates from a transcription start region downstream
of the Dlx1 30end, and overlaps the entire extent of the Dlx1 gene,
continuing well into the upstream neighbor gene of Dlx1,Metap1d
(Kawai et al., 2001). Since Metap1d encodes a mitochondrial-
localized aminopeptidase, while Dlx1 has known functions in the
brain, we have made the assumption that our Dlx1as loss-of-
function phenotype is due to the effect of Dlx1as on Dlx1.
Gamma-amino butyric acid (GABA) is the major neurotrans-
mitter used by the highly diverse group of interneurons found in
the hippocampus (Houser, 2007), yet multiple subpopulations of
interneurons can still be distinguished within this group of
GABAeric interneurons based on morphological and further neu-
rochemical identities (Houser, 2007) with one of the larger
subgroups being Somatostatin and/or Neuropeptide Y expressing
neurons (Houser, 2007; Tallent, 2007) and references therein. In
adult Dlx1 / mice a reduction in Somatostatin, Caltretinin and
Neuropeptide Y producing GABAeric interneurons was reported
causing seizures, hyperexitability and epilepsy when this muta-
tion was maintained on a mixed genetic background (C57BL/
6J:CD1) to allow for postnatal survival (Cobos et al., 2005; Jones
et al., 2011).
Upon ablation of Dlx1as RNA in a mixed C57BL/6J:129SvS2
genetic background, the homozygous animals were fertile and of
normal appearance and survival rate. Mice with an Evf2 loss of
function have been equally described as fertile and morphologi-
cally normal (Bond et al., 2009). When assaying for the expression
of Dlx1, Gad67 and Somatostatin by SISH, we found a two-fold
increase in the number interneurons reaching the detectable
threshold of Dlx1 in the hippocampus of Dlx1as4xPA/4xPA adult
mice, essentially reﬂecting a Dlx1 gain-of-function phenotype.
Similar to data previously generated in vitro, where in a gain-of-
function assay Dlx2 and Dlx5 but not Dlx1 expression was capable
of inducing the expression of glutamic acid decarboxylases
(Stuhmer et al., 2002), we did not observe signiﬁcant changes in
the number of Gad67 or Somatostatin expressing cells when
comparing Dlx1as4xPA/4xPA and Dlx1asþ /þ brains, suggesting a less
dramatic effect in the case of excess Dlx1 transcript compared to
the lack thereof. Hypothetically the observation by Stuhmer et al.
(2002) could be interpreted as a titration effect of the Dlx1as RNA
on excess Dlx1 sense transcript yet not excess transcript of the
other Dlx family members delivered by the over-expression
vector in this gain-of-function experiment. Since surplus Dlx1
transcript delivered by a potent pCAGGS expression vector (Niwa
et al., 1991) does not impact on the number of GABAeric neurons,
the observed two-fold increase in cells reaching detectable levels
of Dlx1 RNA after functional ablation of the Dlx1as RNA is unlikely
to affect the number of GABAeric neurons, yet it might impact on
other interneurons and subpopulations or different cell types, e.g.,
cholinergic neurons or glia not accounted for in our essay
(Furusho et al., 2006; Miyoshi et al., 2007; Ono et al., 2008). It
is of interest though; that Gad67 expression appears unaffected in
the adult hippocampus yet possibly regionally reduced in
embryos after functional ablation of Dlx1as the NAT lncRNA of
the Dlx1/Dlx2 cluster as well Evf2 the NAT lncRNA of the Dlx5/Dlx6
cluster two paralogous genomic regions in close proximity on
mouse chromosome 2. It remains to be discovered to what extent
the apparently reciprocal regulatory modality (Dlx1as down,
Fig. 5. Functional ablation of the Dlx1as RNA transcript increases Dlx1 transcript
abundance mimicking a Dlx1 gain-of function phenotype. (A) Fate determination
of OPCs by controlling transcription levels of Dlx1, Mash1 and Olig2 has been
described previously in various loss-of function experiments (Petryniak et al.,
2007). (B) We believe that the Dlx1as RNA plays a role in modulating Dlx1
transcript availability by impacting on its life span. In a wild type situation, the
hypothetical hybridization between Dlx1 sense transcripts and Dlx1as RNA might
lead to decay of the sense transcript, hence regulating levels and availability of
this transcription factor. In the absence of Dlx1as RNA, the decay could be delayed.
(C) In this gain-of function context owing to a lack or delay of Dlx1 mRNA
degradation, Mash1 and Dlx1 transcript levels were found to be similarly
increased. Excess Dlx1 protein could possibly either direct or via additional
mechanisms impact on Mash1 transcription.
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from the more complex and synergistic regulatory impact of Evf2,
an lncRNA capable of both increasing and decreasing the level of
its NAT partner, Dlx6 (Bond et al., 2009).
Homeodomain (HD) containing proteins, alongside proteins of
the basic helix-loop-helix type (bHLH), are fundamental in
orchestrating neural/glial development in the spinal cord and
brain (Kessaris et al., 2001; Ono et al., 2008). While our qPCR
validation of Olig2 expression on RNA extracted from entire heads
of E13.5 embryos did not show any signiﬁcant difference between
the two genotypes, our SISH data on matching serial sections at
E15.5 hints that the increase in Dlx1 expression in Dlx1as4xPA/4xPA
embryos could possibly have a suppressive effect on Olig2
expression during the differentiation phase of the ﬁrst wave of
OPCs around the time the second wave of OPCs is generated
(Kessaris et al., 2006). This observation would at least be theore-
tically supported by previous data suggesting a negative regula-
tion of Olig2 by Dlx1and Dlx2 given the increase in Olig2
expression in E15.5 Dlx1/Dlx2 mutants (Petryniak et al., 2007).
However, increased Mash1 expression was described in the Dlx1/
Dlx2mutants (Yun et al., 2002) which would also have deleted the
genomic sequence coding for the Dlx1as transcript. While
expanded expression of Dlx1 and Dlx2 was described in the
absence of Mash1 (Casarosa et al., 1999; Horton et al., 1999;
Poitras et al., 2007), Mash1 levels have not been addressed in the
earlier Dlx family gain-of function study in vitro (Stuhmer et al.,
2002). Our qPCR validation shows a statistically signiﬁcant 1.4
upregulation of Mash1 expression on RNA extracted from entire
heads of Dlx1as4xPA/4xPA E13.5 embryos compared to age matched
Dlx1þ /þ . We also observed a slightly broader area of Mash1
expression by SISH in the ventricular and subventricular zone of
Dlx1as4xPA/4xPA embryos at both E12.5 and E15.5 when comparing
matching serial sections. A potential cross-regulation between
Mash1 and Dlx1 and Dlx2 has been described recently (Parras
et al., 2007; Petryniak et al., 2007; Yun et al., 2002). We have not
observed a signiﬁcant change in Dlx2 expression levels at E13.5 in
the absence of functional lnc Dlx1as RNA but we have noted a
signiﬁcant increase in Dlx1 sense transcript levels both by qPCR
validation and SISH. Interestingly in this Dlx1 gain-of-function
situation where the lnc Dlx1as RNA that normally appears to
regulate Dlx1 sense transcript availability, possibly by facilitating
its decay is not functional we also ﬁnd Mash1 expression in the
embryonic brain upregulated at a similar level as Dlx1 expression
itself. We hypothesize that increased Dlx1 sense transcript could
potentially stimulate Mash1 expression, which itself may regulate
Dlx1 sense transcript availability via a feedback loop. However,
given the fact that an increased Mash1 expression was described
in the Dlx1/Dlx2 mutants (Yun et al., 2002) in which based on the
construct design the locus encoding the lnc Dlx1as RNA was also
deleted, a direct supressive effect of this lnc RNA on Mash1
expression cannot be excluded.
Despite a clear effect of the Dlx1as RNA on Mash1 and a
potential effect on later stage Olig2 expression, likely indirect
via modulating Dlx1 transcript stability, our observations and
those of Bond et al. (2009) that the number of GABAeric neurons
in the Dlx1as4xPA/4xPA and Evf2 loss-of-function adult hippocampus
appears unaffected in the absence of functional Dlx1as RNA might
be further explained by studies by Kessaris et al. (2006).
Richardson et al. (2006) showing that in the brain some of the
original OPC populations gradually disappear after birth and are
eventually replaced in the adult. Even more intriguing is an
experiment showing replacement of deliberately killed OPC by
cell populations in the vicinity (Kessaris et al., 2006). Also,
GABAeric neurons, despite being the major neuronal subtype
generated by Olig2þ cells, can develop to normal density in an
Olig2 loss-of function context (Ono et al., 2008). While Dlx1as RNAmight modulate the complex HD/bHLH interplay during embryo-
nic neural/glial development, pathways controlling the numbers
of GABAeric neurons in the adult brain can tolerate the two-fold
increase in Dlx1 expressing cells after its functional ablation.
Effects on other neuronal subtypes and/or their supportive glia
remain to be investigated.
Aside from the neurological defects described for Dlx1and Dlx2
null animals, Depew et al. (2005) identiﬁed a greatly reduced
alicochlear commissure (acc) as an additional phenotype to the
deletion of the proximal ala temporalis in approximately 50% of the
Dlx2 / and in the Dlx1 //Dlx2 / mutants (Liu et al., 1997; Qiu
et al., 1997). Hence we further examined a potential role of the lnc
Dlx1as RNA in skull development. We found in the Dlx1as4xPA/4xPA
mice similar anatomical structures affected as in the Dlx1and Dlx2
null animals, yet in a different way. Depew et al. (2005) describe a
greatly reduced alicochlear commissure (acc) as an additional
phenotype to the deletion of the proximal ala temporalis in
approximately 50% of the Dlx2 / and in the Dlx1 //Dlx2 /
mutants (Liu et al., 1997; Qiu et al., 1997). In the mouse, the origin
of the basisphenoid bone, the hypophyseal cartilage appears just
below the forming pituitary gland by late E13, with the lateral
placed basitrabecular and ala temporalis cartilages being estab-
lished by E15 and the murine chondrocranium being fully formed
by E16 (60). We have observed the appearance of a dysmorphic or
‘‘closed’’ acc at E15.5 in 36% (n¼14) of the Dlx1as4xPA/4xPA genotype
(n¼14) yet none (n¼20) of the Dlx1asþ /þ genotype alicochlear
commissures. This ‘‘closed’’ acc is somewhat opposing the reduced
P. Kraus et al. / Developmental Biology 376 (2013) 224–235 233acc phenotype described for the Dlx2 / and in the Dlx1 //Dlx2 /
mutants. Interestingly, McBratney-Owen et al. (2008) mentioned the
presence of a number of fenestrae in the developing murine chon-
drocranium that are not functioning as openings for nerves or blood
vessels and disappear with ongoing maturation. The ‘‘closed acc’’
dysmorphology we frequently observed for the Dlx1as4xPA/4xPA is
possibly a pre-mature closure of one of those fenestrae in the absence
of functional Dlx1as RNA without any obvious survival consequences
for the animal itself.
In summary, we have proven that Dlx1as RNA is functional, by
using an in vivo gene-targeting approach. We have demonstrated a
skeletal phenotype in the skull base as well as a neurological effect
after the functional ablation of the Dlx1as RNA. Both phenotypes
could possibly be attributed to our abrogation of the negative
regulation of the Dlx1 sense transcript by the Dlx1as RNA transcript.
The precise mechanism remains yet to be discovered: in particular,
it is not clear whether the regulation is nuclear or cytoplasmic, and
whether it is mediated by epigenetic mechanisms (e.g. repressive
histone modiﬁcations as a result of Dlx1as-mediated cis-recruitment
of Prc2 to the Dlx1 locus) or post-transcriptional events (e.g. sense–
antisense hybridization of the two mature, capped, polyadenylated
RNAs, that lessens the half-life or stability of the Dlx1 mRNA),
respectively. There is evidence for Evf2 utilizing both mechanisms as
a NAT of Dlx6 (Bond et al., 2009). Future studies in this ﬁeld should
address both the subcellular localization of Dlx1as and its possible
interactions with RNA-binding proteins. By adding a new piece to
the puzzle of oligodendral/neural fate decision we conclude that
Dlx1as RNA has a function in ﬁne-tuning the accumulation of Dlx1
transcripts and either directly or indirectly impacting on Mash1
transcript levels (Fig. 5).Author contributions
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